Company Filing History:
Years Active: 2008-2013
Title: The Innovative Mind of Binqi Zeng
Introduction
Binqi Zeng, an esteemed inventor based in San Diego, CA, has made significant contributions to the field of kinase inhibition, holding a total of six patents. His groundbreaking work in developing novel compounds has opened new avenues for therapeutic interventions in various diseases.
Latest Patents
Among his latest innovations, Zeng has developed the following notable patents:
1. **Bi-aryl meta-pyrimidine inhibitors of kinases** - This invention provides biaryl meta-pyrimidine compounds with a general structure known for their ability to inhibit kinases, particularly members of the Jak kinase family along with various other specific receptor and non-receptor kinases.
2. **Benzotriazine inhibitors of kinases** - This patent focuses on benzotriazine compounds designed to inhibit kinases, including members of the Src kinase family and various other specific receptor and non-receptor kinases.
Career Highlights
Binqi Zeng's career is marked by his association with Targegen, Inc., a company that specializes in developing innovative medical therapies. His research and the consequent inventions have greatly impacted the pharmaceutical landscape and have paved the way for advancements in targeted therapy.
Collaborations
Throughout his career, Zeng has collaborated with skilled professionals including Glenn Noronha and Chi Ching Mak. These partnerships have enhanced the research and development process, allowing for a more comprehensive approach to innovation in kinase inhibition.
Conclusion
Binqi Zeng's contributions to the field of biotechnology exemplify the power of innovation and collaboration. His continuous efforts in creating effective kinase inhibitors not only showcase his ingenuity as an inventor but also contribute significantly to the advancement of therapeutic practices in medicine. As he forges ahead, the future promises even more groundbreaking inventions from this talented inventor.